¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Abnormal results of pulmonary function studies"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • vegetative function
    ÀÚÀ²±â´É
  • vestibular function test
    ¾È¶ã±â´É°Ë»ç, ÀüÁ¤±â´É°Ë»ç
  • visuoperceptual function assessment
    ½Ã°¢Áö°¢±â´ÉÆò°¡
  • vital function
    »ý¸í±â´É
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • extralobar pulmonary sequestration
    ¿±¿ÜÇãÆÄºÐ¸®Áõ, ¿±¿ÜÆóºÐ¸®Áõ
  • hypertrophic pulmonary osteoarthropathy
    ºñ´ë¼ºÆó»À°üÀýº´(Áõ)
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
  • hantavirus pulmonary syndrome
    ÇÑŸ¹ÙÀÌ·¯½ºÆóÁõÈıº
  • idiopathic pulmonary fibrosis
    Ư¹ßÆó¼¶À¯Áõ
  • intralobar pulmonary sequestration
    ¿±³»ÇãÆÄºÐ¸®Áõ, ¿±³»ÆóºÐ¸®Áõ
  • neurogenic pulmonary edema
    ½Å°æ¼ºÆóºÎÁ¾
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´(Áõ)
  • pulmonary
    Æó-, ÇãÆÄ-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • municipal health function
    µµ½Ãº¸°Ç±â´É
  • phonatory function
    ¹ß¼º±â´É
  • reflex function
    ¹Ý»ç±â´É
  • somatosensory function
    ¸ö°¨°¢±â´É
  • survival function
    »ýÁ¸ÇÔ¼ö
  • vegetative function
    Áõ½Ä´É
  • vital function
    »ý¸í±â´É
  • liver function test
    °£±â´É°Ë»ç
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • righting function test
    ¹Ù·Î¼­±â±â´É°Ë»ç
  • vestibular function test
    ÀüÁ¤±â´É°Ë»ç, ¾È¶ã±â´É°Ë»ç
  • plexogenic pulmonary arteriopathy
    ¾ó±âÇü¼ºÆóµ¿¸Æº´Áõ
  • pulmonary actinomycosis
    ÇãÆÄ¹ÙÄû»ì±ÕÁõ, Æó¹æ¼±±ÕÁõ
  • pulmonary alveolus
    ÇãÆÄ²Ê¸®, ÆóÆ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • holding function
    ÁöÁö ±â´É(ò¨ò¥ ѦÒö)
  • homeostatic function
    Ç×»ó¼º ±â´É(ѦÒö).
  • immunologic function
    ¸é¿ª±â´É.
  • phonatory function
    ¹ß¼º±â´É(¡­Ñ¦Òö).
  • phonatory function
    ¹ß¼º±â´É
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postictal disturbance of cerebral function
    ¹ßÀÛÈÄ´ë³ú±â´ÉÀå¾Ö(Û¡íÂý­ÓÞÒà ѦÒöî¡äô).
  • power function graph
    Èû±â´É±×·¡ÇÁ
  • primitive function
    ¿ø½Ã±â´É(ÊÙË»ËÀ).
  • probability function
    È®·üÇÔ¼ö(ÊṴ̀Ëà).
  • radial function
    µ¿°æÇÔ¼ö(ÔÑÌÓùÞâ¦).
  • regular function
    Á¤»ó±â´É(ïáßÈѦÒö).
  • renal function
    ½Å±â´É(ãìѦÒö).
  • renal function testing
    ½Å±â´É°Ë»ç
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • binocular function
    ¾ç¾È½Ã±â´É
  • bone marrow function test
    °ñ¼ö±â´É°Ë»ç (¡­Ñ¦ÒöËþÞÛ).
  • brain function mapping
    ³ú±â´É ÁöµµÈ­
  • cardiac function curve
    ½É±â´É°î¼±(ãýѦÒöÍØàÊ).
  • cardiac function curve
    ½ÉÀå±â´É°î¼±(ãýíôѦÒöÍØàÊ)
  • colonic function
    ´ëÀå±â´É(ÓÞíóѦÒö)
  • colonic function
    ´ëÀå±â´É(ÓÞíóѦÒö).
  • conceptual function
    °³³ä±â´É(ËÈҷѦÒö)
  • cumulative distribution function =CDF
    ´©ÀûºÐÆ÷°è¼ö(ÊÙËÓ̰ Ëà).
  • discriminative sensory function
    ½Äº°°¨°¢±â´É(¡­ÊïÊÆÑ¦Òö).
  • distribution function
    ºÐÆ÷±â´É, ºÐÆ÷ÇÔ¼ö.
  • elliptic function
    Ÿ¿øÇÔ¼ö( ê­ùÞâ¦).
  • executant ego function
    ÁýÇàÀû ÀھƱâ´É.
  • executive function
    ½ÇÇ༺ ±â´É(ãùú¼àõѦÒö).
  • exponential function
    Áö¼öÇÔ¼ö.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Pulmonary root
    ÇãÆÄ»Ñ¸®
    [¿¾ ¿ë¾î] Æó±Ù
  • Pulmonary juxtaesophageal lymph nodes
    ÇãÆÄ½Äµµ¿·¸²ÇÁÀý
    [¿¾ ¿ë¾î] Æó½Äµµ¹æÀÓÆÄÀý
  • Pulmonary plexus
    ÇãÆÄ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Æó½Å°æÃÑ
  • Pulmonary bud
    ÇãÆÄ½Ï
    [¿¾ ¿ë¾î] Æó·Ú
  • Pulmonary ligament
    ÇãÆÄÀδë
    [¿¾ ¿ë¾î] Æó°£¸·
  • Pulmonary vein
    ÇãÆÄÁ¤¸Æ
    [¿¾ ¿ë¾î] ÆóÁ¤¸Æ
  • Orifices of pulmonary veins
    ÇãÆÄÁ¤¸Æ±¸¸Û
    [¿¾ ¿ë¾î] ÆóÁ¤¸Æ±¸
  • Visceral [pulmonary] pleura
    ÇãÆÄÂʰ¡½¿¸·
    [¿¾ ¿ë¾î] ÆóÈ丷
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pulmonary congestion
    Æó¿ïÇ÷
  • pulmonary edema
    ÆóºÎÁ¾
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ
  • pulmonary emphysema
    Æó±âÁ¾
  • pulmonary eosinophilia
    ÆóÈ£»ê±¸Áõ°¡Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • pulmonary hemorrhage
    ÆóÃâÇ÷
  • pulmonary hypertrophic osteopathy
    Æó¼ººñ´ë¼º°ñº´Áõ
  • pulmonary infarction
    Æó°æ»öÁõ
  • pulmonary infiltration
    ÆóħÀ±
  • pulmonary meniscus sign
    ÆóÃʽ´Þ¡ÈÄ
  • pulmonary proteinosis
    ÆóÆ÷´Ü¹éÁõ
  • pulmonary reticuloendotheliosis
    Æó¼¼¸Á³»ÇÇÁõ
  • pulmonary sarcoidosis
    Æó»ç¸£ÄÚÀ̵åÁõ
  • pulmonary sequestration
    ÆóºÐ¸®Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RR radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati...
SEER Surveillance Epidemiology and End Results [Program]
LFA left femoral artery; left frontal craniotomy; left fronto-anterior [fetal position]; leukocyte funct...
LFT latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio...
SFI Sexual Function Index; Social Function Index
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PF pulmonary function
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chemotactic function
    È­ÇÐ ÁÖ¼º ±â´É
  • colonic function
    ´ëÀå ±â´É
  • convex function
    º¼·Ï ÇÔ¼ö
  • executive function
    ½ÇÇ༺ ±â´É
  • function
    ±â´É
    ¾î¶² Àå±â³ª ºÎºÐÀÇ Æ¯¼öÇϰí Á¤»óÀûÀÎ ¶Ç´Â °íÀ¯ÇÑ »ý¸®Àû Ȱµ¿.
  • function modification
    ±â´É º¯Çü
  • function of saliva
    Ÿ¾×ÀÇ ±â´É
  • function test
    ±â´É ½ÃÇè
  • immunologic function
    ¸é¿ª ±â´É
  • labyrinthine function
    ¹Ì·Î ±â´É
  • language function
    ¾ð¾î ±â´É
  • logarithmic function
    ·Î±× ÇÔ¼ö
    ÇØ¼®ÇÐ ¿ë¾î. a¸¦ 1ÀÌ ¾Æ´Ñ ¾çÀÇ »ó¼ö¶ó°í ÇÒ ¶§, µÎ º¯¼ö x¿Í y »çÀÌ¿¡ a=xÀÎ °ü°è°¡ ÀÖÀ¸¸é y´Â a¸¦ ¹ØÀ¸·Î ÇÏ´Â xÀÇ ·Î±× ÇÔ¼ö¶ó Çϰí, y£½log x·Î ³ªÅ¸³½´Ù.
  • mixed function oxidase
    È¥ÇÕ ±â´É ¿Á½Ãµ¥À̽º
  • myocardial function
    ½É±Ù ±â´É
  • neuromuscular function
    ±Ù½Å°æ ±â´É
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
epidemiologic studies Studies designed to examine associations, commonly, hypothesised causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are case-control studies, cohort studies, and cross-sectional studies.
(12 Dec 1998)
evaluation studies Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, clinical trials, drug evaluation, and drug screening are available.
(12 Dec 1998)
twin studies Methods of detecting genetic aetiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilised ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies.
(12 Dec 1998)
feasibility studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.
(12 Dec 1998)
follow-up studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
(12 Dec 1998)
longitudinal studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
(12 Dec 1998)
acquired platelet function defect <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(29 Dec 1997)
allomeric function The combined function of the several segments of the spinal cord and medulla, communicating with each other by means of the white matter.
(05 Mar 2000)
aperture function <microscopy> In a diffraction-limited optical system, the function that determines the relationship between the image and each point in the object. Modifying the aperture function changes the image according to the modified Fourier-filtering (or optical filtration) property of the aperture.
(05 Aug 1998)
arousal function The ability of a sensory event to arouse the cortex to vigilance or readiness.
(05 Mar 2000)
atrial function The haemodynamic and electrophysiological action of the atria.
(12 Dec 1998)
atrial function, left The haemodynamic and electrophysiological action of the left atrium.
(12 Dec 1998)
atrial function, right The haemodynamic and electrophysiological action of the right atrium.
(12 Dec 1998)
atrial transport function The role of the atria in filling and stretching the ventricles by their presystolic contraction, without which the force of ventricular contraction and hence the cardiac output may significantly decrease.
(05 Mar 2000)
pancreatic function tests Tests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á